نتایج جستجو برای: bzd

تعداد نتایج: 219  

A Shafiee M Binesh Marvasti M Sharifzadeh M Shekarchi

Anticonvulsant activity of 7-phenyl-5H-thiazolo[5,4-e][1,2,3,4]tetrazolo[5,1-c]pyrrolo[1,2-a][1,4]diazepine (5) and 7-phenyl-5H-thiazolo[5,4-e][1,3,4]triazolo[5,1-c]pyrrolo[1,2-a][1,4]diazepines (6a-d) was measured against pentylenetetrazole (PTZ)-induced seizures in mice. Intraperitoneal injections of different doses (12.5, 25 and 50 mg/kg, i.p.) of test compounds decreased PTZ-induced seizure...

Journal: :Adv. Comput. Math. 2014
Hans G. Feichtinger Anna Grybos Darian M. Onchis

Regular Gabor frames for L2(Rd) are obtained by applying time-frequency shifts from a lattice in Λ Rd× R̂d to some decent so-called Gabor atom g, which typically is something like a summability kernel in classical analysis, or a Schwartz function, or more generally some g∈ S0(R). There is always a canonical dual frame, generated by the dual Gabor atom g̃. The paper promotes a numerical approach f...

Journal: :Research, Society and Development 2023

Os benzodiazepínicos (BZD’s) são drogas psicoativas que atuam como moduladores alostéricos (agonistas) do receptor de ácido γ-aminobutírico tipo A (GABAA), Sistema Nervoso Central, na prática clínica, esses medicamentos muitos utilizados e prescritos no tratamento da ansiedade, insônia depressão. Devido suas várias ações farmacológicas, o uso prolongado, torna entre os cincos fármacos mais vend...

2011
Gabriel Hancu

The applicability of micellar electrokinetic capillary chromatography (MEKC) for the separation of benzodiazepine (BZD) derivates with different structural characteristics has been studied. Efforts were first focused on the optimization of the analytical conditions, on the effects of buffer concentration, surfactant concentration and buffer pH on the separation. To manipulate selectivity of the...

Journal: :CNS neuroscience & therapeutics 2016
Benjamin Rolland François Paille Claudine Gillet Alain Rigaud Romain Moirand Corine Dano Maurice Dematteis Karl Mann Henri-Jean Aubin

BACKGROUND The latest French good practice recommendations (GPRs) for the screening, prevention, and treatment of alcohol misuse were recently published in partnership with the European Federation of Addiction Societies (EUFAS). This article aims to synthesize the GPRs focused on the pharmacotherapy of alcohol dependence. METHODS A four-member European steering committee defined the questions...

2015
Kateryna Bielka Iurii Kuchyn Felix Glumcher

BACKGROUND Dexmedetomidine (DEX) is a centrally acting alpha-2-adrenoceptor agonist that has potential in the management of alcohol withdrawal syndrome (AWS) owing to its ability to produce arousable sedation and to inhibit the adrenergic system without respiratory depression. The objective of this randomized controlled study was to evaluate whether addition of DEX to benzodiazepine (BZD) thera...

Journal: :acta medica iranica 0
mohammad esmaeil tashayod

this paper deals with the assessment of the depth of the modern anesthesia. a new classification is proposed and a test is designed for monitoring the movement of the hand during complete relaxation.

Journal: :Neuropsychiatric Disease and Treatment 2007
Jaime M Monti SR Pandi-Perumal

Eszopiclone is the S-isomer of racemic zopiclone, a cyclopyrrolone with sedative-hypnotic activity that has been available in Europe, Canada, and Latin America since 1987. Eszopiclone acts by binding to the GABA(A) receptor. In contrast to the benzodiazepine (BZD) hypnotics, eszopiclone has more selectivity for certain subunits of the GABA(A) receptor. Oral eszopiclone is rapidly absorbed and e...

Journal: :European Psychiatry 2023

Introduction While the role of benzodiazepines (BZDs) has been well established for anxiety and related disorders, there are significant concerns about BZD dependence, withdrawal, tolerance. There is a lot ambiguity regarding potential long-term effects BZDs on mental health. However, risk developing subsequent other substance use disorders in question. Objectives In this electronic medical rec...

2016
Jaime M. Monti

Several agents are known to improve sleep induction and/or maintenance in patients with insomnia disorder. These include the benzodiazepine (BZD) and non-BZD receptor allosteric modulators, the melatonin receptor agonist ramelteon, low-dose doxepin, and suvorexant. One of the drawbacks of the BZDs is their known reduction in both N3 sleep [also known as slow wave sleep or delta sleep and charac...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید